Clinical Nurse Specialist, Adult Health · Mason City, IA
NPI
1588289672
Since 2020
Specialty
Clinical Nurse Specialist, Adult Health
Code 364SA2200X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1000 4th St SW
Mason City, IA, 50401
Phone (641) 428-6300
Groups this clinician bills Medicare through
Medicare paid, 2024
$35K
662 services
Medicare patients, 2024
296
Average age 76
Drug cost, 2024
$3.1M
722 prescriptions
Company payments, 2025
$25.62
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Heidi Smith was code 99214 (office e&m - established), 515 times for 227 patients. In total Heidi Smith billed 662 services in 7 codes, and Medicare paid $35K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-07-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 515 | 227 | $57.58 | $30K |
| 99213 Office E&M - Established | Facility | 117 | 89 | $37.61 | $4,400 |
| 38222 Other Organ Systems | Facility | 23 | 23 | $46.40 | $1,067 |
By year: 2022 $43K for 761 services; 2023 $43K for 809 services; 2024 $35K for 662 services.
Medicare prescription drug claims, 2024
In 2024, the drug Heidi Smith prescribed most often to Medicare patients was Hydroxyurea, with 68 prescriptions and refills. In total Heidi Smith wrote 722 Medicare prescriptions that cost $3.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxyurea Generic | 68 | 123 | 15 | $1,096 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 34 | 36 | Under 11 | $156 |
| Brukinsa Zanubrutinib | 33 | 33 | Under 11 | $496K |
| Imbruvica Ibrutinib | 28 | 28 | Under 11 | $397K |
| Gabapentin Generic | 27 | 51 | Under 11 | $264 |
| Acyclovir Generic | 26 | 28 | Under 11 | $155 |
| Eliquis Apixaban | 25 | 30 | Under 11 | $17K |
| Imatinib Mesylate Generic | 22 | 22 | Under 11 | $4,039 |
| Famotidine Generic | 22 | 23 | Under 11 | $121 |
| Xtandi Enzalutamide | 20 | 20 | Under 11 | $273K |
| Prednisone Generic | 19 | 25 | Under 11 | $126 |
| Abiraterone Acetate Generic | 19 | 19 | Under 11 | $16K |
| Tukysa Tucatinib | 18 | 18 | Under 11 | $464K |
| Anastrozole Generic | 16 | 42 | Under 11 | $409 |
| Potassium Chloride Generic | 14 | 14 | Under 11 | $125 |
Brand drugs: 210 claims; generic drugs: 512 claims; opioid claims: 32.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Heidi Smith $25.62 ($25.62 in general payments such as food, travel and fees) from 1 company. The largest payer was Novocure Inc. with $25.62.
| Company | Payments | Amount |
|---|---|---|
| Novocure Inc. NVCR | 1 | $25.62 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.